U.S., Oct. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07205666) titled 'The Eplontersen Pregnancy and Lactation Outcomes Study' on Sept. 17.
Brief Summary: The overall objective of this DPSS is to describe the occurrence of pregnancy and maternal complications, adverse effects on the developing fetus and neonate, and adverse effects on the infant associated with exposure to eplontersen during pregnancy and/or lactation.
Study Start Date: Nov. 30
Study Type: OBSERVATIONAL
Condition:
Transthyretin Amyloidosis
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Published by HT Digital Content Services with permission from Health Daily Digest....